GlassScriptPhysician profile
Yueh B Lee
NPI 1962472571
$94,928.98
in general payments reported to CMS, 2019-2025
20 companies · $398 in 2025
The $398 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,051 · 2020: $1,082 · 2021: $2,763 · 2022: $70K · 2023: $7,894 · 2024: $12K · 2025: $398.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $9,400 · Acquisitions: $9,291 · Food and Beverage: $1,331.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $9,400.00 |
| Acquisitions | $9,290.76 |
| Food and Beverage | $1,330.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linvatec Corporation | $78,679.99 | 2022-2025 | Avenger Radial Head, +4 Stems, Biobrace 23mm, Neospan |
| Skye Orthobiologics LLC | $9,400.00 | 2024 | |
| Treace Medical Concepts, INC. | $2,625.62 | 2021-2024 | |
| In2bones USA, LLC | $2,137.76 | 2020-2022 | |
| Stryker Corporation | $551.42 | 2019 | |
| Paratek Pharmaceuticals, INC. | $378.74 | 2024-2025 | Nuzyra |
| Ossio INC | $198.12 | 2021-2023 | |
| Merck Sharp & Dohme LLC | $196.37 | 2019 | |
| Arthrex, INC. | $155.29 | 2019-2022 | |
| Crossroads Extremity Systems, LLC | $110.51 | 2021 | |
| Horizon Therapeutics Plc | $105.87 | 2019-2021 | |
| Globus Medical, INC. | $95.12 | 2023 | Mini Fragment System, Ankle Fracture System |
| Melinta Therapeutics, LLC | $92.60 | 2019 | |
| Depuy Synthes Sales INC. | $51.01 | 2019-2025 | Motoband |
| Nabriva Therapeutics, Plc | $45.44 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $30.72 | 2025 | Krystexxa |
| Bioventus LLC | $25.14 | 2019 | |
| Zyla Life Sciences, INC. | $21.60 | 2020 | |
| Arteriocyte Medical Systems, INC. | $15.52 | 2019 | |
| Ermi LLC | $12.14 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yueh Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.